|
1
|
Mayeux R: Epidemiology of
neurodegeneration. Annu Rev Neurosci. 26:81–104. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spillantini MG, Schmidt ML, Lee VM,
Trojanowski JQ, Jakes R and Goedert M: Alpha-synuclein in Lewy
bodies. Nature. 388:839–840. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spillantini MG, Crowther RA, Jakes R,
Hasegawa M and Goedert M: alpha-Synuclein in filamentous inclusions
of Lewy bodies from Parkinson's disease and dementia with lewy
bodies. Proc Natl Acad Sci USA. 95:6469–6473. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wood-Kaczmar A, Gandhi S and Wood NW:
Understanding the molecular causes of Parkinson's disease. Trends
Mol Med. 12:521–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tenreiro S, Reimão-Pinto MM, Antas P, Rino
J, Wawrzycka D, Macedo D, Rosado-Ramos R, Amen T, Waiss M,
Magalhães F, et al: Phosphorylation modulates clearance of
alpha-synuclein inclusions in a yeast model of Parkinson's disease.
PLoS Genet. 10:e10043022014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clarimón J and Kulisevsky J: Parkinson's
disease: From genetics to clinical practice. Curr Genomics.
14:560–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chartier-Harlin MC, Kachergus J, Roumier
C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J,
Hulihan M, et al: Alpha-synuclein locus duplication as a cause of
familial Parkinson's disease. Lancet. 364:1167–1169. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dorval V, Mandemakers W, Jolivette F,
Coudert L, Mazroui R, De Strooper B and Hébert SS: Gene and
MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse
models. PLoS One. 9:e855102014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cardo LF, Coto E, De Mena L, Ribacoba R,
Moris G, Menéndez M and Alvarez V: Profile of microRNAs in the
plasma of Parkinson's disease patients and healthy controls. J
Neurol. 260:1420–1422. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Margis R, Margis R and Rieder CR:
Identification of blood microRNAs associated to Parkinsonĭs
disease. J Biotechnol. 152:96–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lesnick TG, Papapetropoulos S, Mash DC,
Ffrench-Mullen J, Shehadeh L, De Andrade M, Henley JR, Rocca WA,
Ahlskog JE and Maraganore DM: A genomic pathway approach to a
complex disease: Axon guidance and Parkinson disease. PLoS Genet.
3:e982007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martins M, Rosa A, Guedes LC, Fonseca BV,
Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, et
al: Convergence of miRNA expression profiling, α-synuclein
interacton and GWAS in Parkinson's disease. PLoS One. 6:e254432011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
da W Huang, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
16
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee RC, Feinbaum RL and Ambros V: The C.
Elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mouradian MM: MicroRNAs in Parkinson's
disease. Neurobiol Dis. 46:279–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miñones-Moyano E, Porta S, Escaramís G,
Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I,
Estivill X and Martí E: MicroRNA profiling of Parkinson's disease
brains identifies early downregulation of miR-34b/c which modulate
mitochondrial function. Hum Mol Genet. 20:3067–3078. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho HJ, Liu G, Jin SM, Parisiadou L, Xie
C, Yu J, Sun L, Ma B, Ding J, Vancraenenbroeck R, et al:
MicroRNA-205 regulates the expression of Parkinson's
disease-related leucine-rich repeat kinase 2 protein. Hum Mol
Genet. 22:608–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doxakis E: Post-transcriptional regulation
of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem.
285:12726–12734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu J, Kao SY, Lee FJ, Song W, Jin LW and
Yankner BA: Dopamine-dependent neurotoxicity of alpha-synuclein: A
mechanism for selective neurodegeneration in Parkinson disease. Nat
Med. 8:600–606. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goldstein M and Lieberman A: The role of
the regulatory enzymes of catecholamine synthesis in Parkinson's
disease. Neurology. 424(4 Suppl 4): 8–12, 41–48. 1992.
|
|
25
|
Guo C, Degnin CR, Laederich MB, Lunstrum
GP, Holden P, Bihlmaier J, Krakow D, Cho YJ and Horton WA: Sprouty
2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A
severe form of human achondroplasia. Cell Signal. 20:1471–1477.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gross I, Armant O, Benosman S, De Aguilar
JL, Freund JN, Kedinger M, Licht JD, Gaiddon C and Loeffler JP:
Sprouty2 inhibits BDNF-induced signaling and modulates neuronal
differentiation and survival. Cell Death Differ. 14:1802–1812.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Simón-Sánchez J, Van Hilten JJ, van De
Warrenburg B, Post B, Berendse HW, Arepalli S, Hernandez DG, De Bie
RM, Velseboer D, Scheffer H, et al: Genome-wide association study
confirms extant PD risk loci among the Dutch. Eur J Hum Genet.
19:655–661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miska EA, Alvarez-Saavedra E, Townsend M,
Yoshii A, Sestan N, Rakic P, Constantine-Paton M and Horvitz HR:
Microarray analysis of microRNA expression in the developing
mammalian brain. Genome Biol. 5:R682004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aschrafi A, Schwechter AD, Mameza MG,
Natera-Naranjo O, Gioio AE and Kaplan BB: MicroRNA-338 regulates
local cytochrome c oxidase IV mRNA levels and oxidative
phosphorylation in the axons of sympathetic neurons. J Neurosci.
28:12581–12590. 2008. View Article : Google Scholar : PubMed/NCBI
|
